 |
CORSO: Cancer Translational Research: from molecular biology to the real world setting
Chieti, 20 April 2018 |
Direttore: Clara Natoli |
| CREDITI ECM: 6 |
SCARICA IL PDF... |
|
|
|
|
|
|
|
|
| PROGRAMMA DEL CORSO (CLICCARE SULLE ICONE PER SCARICARE LE SLIDES) |
| 09:00 |
Registration & Welcome coffee |
|
|
|
| 09:30 |
Welcome from
Luigi Capasso - Presidente Fondazione Università Gabriele D'Annunzio
Agostino Consoli - Direttore CESI-MeT
Patrizia Di Iorio - Presidente Scuola di Medicina e Scienze della Salute - Chieti
|
|
|
|
|
| SESSION I |
| Moderatori: Roberta di Pietro, Alessandro Cama |
|
| 09:50 |
The canine model in the cancer fight: role of comparative oncology in translational research |
Mariarita Romanucci, Leonardo Della Salda |
|
|
| 10:10 |
Telomeric activities of the PML protein in normal and neoplastic cells |
Francesco Grignani |
|
|
| 10:20 |
Sarcomas: a model for translational medicine |
Massimo Aglietta |
|
|
|
|
|
| Session II |
| Moderatori: Marina Scarpelli, Antonio Marchetti |
|
| 10:50 |
The present and future of biomarkers in prostate cancer: proteomics and genomics |
Arcangelo Sebastianelli, Marco Carini |
|
|
| 11:10 |
Asbestost and intrahepatic cholangiocarcinoma: from epidemiology to NGS |
Giovanni Brandi |
|
|
| 11:30 |
New potentials for liquid biopsies in oncology |
Marta Castiglia, Antonio Russo |
|
|
|
|
|
|
|
| Session III |
| Felice Mucilli, Domenico Genovesi |
| 12:30 |
The world of the EGF-Receptor: focus on lung cancer |
Roberto Bianco |
|
|
| 12:50 |
First line treatment of metastatic colorectal cancer: from RCT to clinical practice |
Nicola Tinari, Clara Natoli |
|
|
|
|
|
|
|
| Session IV |
| Moderatori: Adriano Piattelli, Raffaella Muraro |
|
| 14:30 |
New therapies in oncology: focus on oral complications |
Lorenzo Lo Muzio |
|
|
|
|
|
| Session V |
| Moderatori: Ettore Cianchetti, Corrado Ficorella |
|
| 15:10 |
PAM50 in breast cancer |
Giuseppe Tonini |
|
|
| 15:30 |
Luminal Metastatic Breast Cancer: role of CDK4/6 inhibitors from preclinical data to clinical practice |
Vincenzo Adamo |
|
|
| 15:50 |
Highlights on triple positive breast cancer |
Patrizia Querzoli |
|
|
| 16:10 |
HER2+ breast cancer: from RCT to the real world scenario |
Antonino Grassadonia, Clara Natoli |
|
|
|
|
|
|
|
| Session VI |
| Moderatori: Liborio Stuppia, Clara Natoli |
|
| 17:00 |
BRCA1 and BRCA2 mutations in breast or ovarian cancer probands at risk of genetic predisposition |
Tina Sidoni, Corrado Ficorella |
|
|
| 17:20 |
PARP Inhibitors in breast cancer treatment |
Silverio Tomao |
|
|
|
|
| 18:00 |
Take-home messages and conclusions |
Clara Natoli |
|
|